Medical Developments International Ltd
Medical Developments International Limited is an Australia-based company that delivers emergency medical solutions dedicated to improving patient outcomes in both domestic and international markets.
The business
Medical Developments International Limited is an Australia-based company that delivers emergency medical solutions dedicated to improving patient outcomes in both domestic and international markets. The Company operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The Company manufactures an inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. The respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.
Small Caps Research
No research on Medical Developments International Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise MVP based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news

Medical Developments International Builds Penthrox Momentum on Improved Cash Flow
Medical Developments International ups FY26 revenue 9% to $42.6m; Penthrox demand boosts cash flow; paediatric approval expands UK/Europe use, driving momentum.

Medical Developments International Achieves Positive Cash Flow in Strong Q3 Performance
Medical Developments International posts strong Q3 FY26: revenue $10.5m up 19%, positive cash flow and progress on European paediatric Penthrox approvals.

Medical Developments strikes deal with Daiichi Sankyo to export Penthrox green whistle to China
Medical solutions company Medical Developments International (ASX: MVP) has set out intentions to expand its market presence by signing an exclusive distribution and license agreement with Tokyo-listed Daiichi Sankyo for its Penthrox drug in China, Thailand and Vietnam. According to the terms of the deal, Daiichi Sankyo will pay Medical Developments as much as US$32.5 […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.